Search

Your search keyword '"Marr, Celia"' showing total 264 results
Start Over Author "Marr, Celia"
264 results on '"Marr, Celia"'

4. High-Resolution Genotyping of Expressed Equine MHC Reveals a Highly Complex MHC Structure

Author

Vasoya, Deepali, Tzelos, Thomas, Benedictus, Lindert, Karagianni, Anna Eleonora, Pirie, Scott, Marr, Celia, Oddsdóttir, Charlotta, Fintl, Constanze, Connelley, Timothy, Vasoya, Deepali, Tzelos, Thomas, Benedictus, Lindert, Karagianni, Anna Eleonora, Pirie, Scott, Marr, Celia, Oddsdóttir, Charlotta, Fintl, Constanze, and Connelley, Timothy

Abstract

The Major Histocompatibility Complex (MHC) genes play a key role in a number of biological processes, most notably in immunological responses. The MHCI and MHCII genes incorporate a complex set of highly polymorphic and polygenic series of genes, which, due to the technical limitations of previously available technologies, have only been partially characterized in non-model but economically important species such as the horse. The advent of high-throughput sequencing platforms has provided new opportunities to develop methods to generate high-resolution sequencing data on a large scale and apply them to the analysis of complex gene sets such as the MHC. In this study, we developed and applied a MiSeq-based approach for the combined analysis of the expressed MHCI and MHCII repertoires in cohorts of Thoroughbred, Icelandic, and Norwegian Fjord Horses. The approach enabled us to generate comprehensive MHCI/II data for all of the individuals ( n = 168) included in the study, identifying 152 and 117 novel MHCI and MHCII sequences, respectively. There was limited overlap in MHCI and MHCII haplotypes between the Thoroughbred and the Icelandic/Norwegian Fjord horses, showcasing the variation in MHC repertoire between genetically divergent breeds, and it can be inferred that there is much more MHC diversity in the global horse population. This study provided novel insights into the structure of the expressed equine MHC repertoire and highlighted unique features of the MHC in horses.

Published
2023

5. High-Resolution Genotyping of Expressed Equine MHC Reveals a Highly Complex MHC Structure

Author

FAH veterinaire epidemiologie, Vasoya, Deepali, Tzelos, Thomas, Benedictus, Lindert, Karagianni, Anna Eleonora, Pirie, Scott, Marr, Celia, Oddsdóttir, Charlotta, Fintl, Constanze, Connelley, Timothy, FAH veterinaire epidemiologie, Vasoya, Deepali, Tzelos, Thomas, Benedictus, Lindert, Karagianni, Anna Eleonora, Pirie, Scott, Marr, Celia, Oddsdóttir, Charlotta, Fintl, Constanze, and Connelley, Timothy

Published
2023

6. Non-invasive methods for the investigation of soft tissue injury in the equine limb : diagnostic ultrasonography and microwave thermography

Author

Marr, Celia M.

Subjects
636.1
Abstract

A technique was established for the examination of the soft tissue structures of the palmar aspect of the distal equine limb using an ultrasonographic unit equipped with a 7.5 MHz linear array transducer and a separate echolucent stand-off block by performing examinations in six cadaver limbs and in twenty-five adult Thoroughbred horses. The flexor tendons had shapes on ultrasonograms which corresponded with their expected anatomy and their size varied along their length. The lateral to medial and dorsal to palmar dimensions of the flexor tendon were correlated with each other and with the age, weight and height of the horse, the limb circumference and metacarpal bone diameter but consistent relationships between pairs of variables were not evident although the correlation between a variety of individual pairs was significant (p< 0.05).

Published
1990

10. Cardiac ion channel expression in the equine model ‐ In‐silico prediction utilising RNA sequencing data from mixed tissue samples

Author

Premont, Antoine, Saadeh, Khalil, Edling, Charlotte, Lewis, Rebecca, Marr, Celia M, Jeevaratnam, Kamalan, Jeevaratnam, Kamalan [0000-0002-6232-388X], and Apollo - University of Cambridge Repository

Subjects
Sequence Analysis, RNA, Physiology, calcium-handling proteins, cardiomyocyte, Arrhythmias, Cardiac, equine cardiac electrophysiology, Ion Channels, in‐silico prediction, cardiac arrhythmia, transcriptomics, in-silico prediction, Physiology (medical), calcium‐handling proteins, Animals, Humans, RNA, Calcium, Myocytes, Cardiac, Horses, ORIGINAL ARTICLES, ORIGINAL ARTICLE, sodium channel
Abstract

Funder: University of Surrey; Id: http://dx.doi.org/10.13039/501100003513, Understanding cardiomyocyte ion channel expression is crucial to understanding normal cardiac electrophysiology and underlying mechanisms of cardiac pathologies particularly arrhythmias. Hitherto, equine cardiac ion channel expression has rarely been investigated. Therefore, we aim to predict equine cardiac ion channel gene expression. Raw RNAseq data from normal horses from 9 datasets was retrieved from ArrayExpress and European Nucleotide Archive and reanalysed. The normalised (FPKM) read counts for a gene in a mix of tissue were hypothesised to be the average of the expected expression in each tissue weighted by the proportion of the tissue in the mix. The cardiac-specific expression was predicted by estimating the mean expression in each other tissues. To evaluate the performance of the model, predicted gene expression values were compared to the human cardiac gene expression. Cardiac-specific expression could be predicted for 91 ion channels including most expressed Na+ channels, K+ channels and Ca2+ -handling proteins. These revealed interesting differences from what would be expected based on human studies. These differences included predominance of NaV 1.4 rather than NaV 1.5 channel, and RYR1, SERCA1 and CASQ1 rather than RYR2, SERCA2, CASQ2 Ca2+ -handling proteins. Differences in channel expression not only implicate potentially different regulatory mechanisms but also pathological mechanisms of arrhythmogenesis.

Published
2022
Full Text
View/download PDF

11. ECG Restitution Analysis and Machine Learning to Detect Paroxysmal Atrial Fibrillation: Insight from the Equine Athlete as a Model for Human Athletes

Author

Huang, Ying H, Alexeenko, Vadim, Tse, Gary, Huang, Christopher L-H, Marr, Celia M, Jeevaratnam, Kamalan, Jeevaratnam, Kamalan [0000-0002-6232-388X], and Apollo - University of Cambridge Repository

Subjects
Machine Learning, Electrocardiography, ECG, equine athletes, Heart Rate, Atrial Fibrillation, diagnostic, Humans, Animals, Horses, paroxysmal atrial fibrillation, restitution analysis
Abstract

Atrial fibrillation is the most frequent arrhythmia in both equine and human athletes. Currently, this condition is diagnosed via electrocardiogram (ECG) monitoring which lacks sensitivity in about half of cases when it presents in paroxysmal form. We investigated whether the arrhythmogenic substrate present between the episodes of paroxysmal atrial fibrillation (PAF) can be detected using restitution analysis of normal sinus-rhythm ECGs. In this work, ECG recordings were obtained during routine clinical work from control and horses with PAF. The extracted QT, TQ, and RR intervals were used for ECG restitution analysis. The restitution data were trained and tested using k-nearest neighbor (k-NN) algorithm with various values of neighbors k to derive a discrimination tool. A combination of QT, RR, and TQ intervals was used to analyze the relationship between these intervals and their effects on PAF. A simple majority vote on individual record (one beat) classifications was used to determine the final classification. The k-NN classifiers using two-interval measures were able to predict the diagnosis of PAF with area under the receiving operating characteristic curve close to 0.8 (RR, TQ with k ≥ 9) and 0.9 (RR, QT with k ≥ 21 or TQ, QT with k ≥ 25). By simultaneously using all three intervals for each beat and a majority vote, mean area under the curves of 0.9 were obtained for all tested k-values (3-41). We concluded that 3D ECG restitution analysis can potentially be used as a metric of an automated method for screening of PAF.

Published
2022
Full Text
View/download PDF

12. Atrial fibrillatory rate as predictor of recurrence of atrial fibrillation in horses treated medically or with electrical cardioversion

Author

Buhl, Rikke, Hesselkilde, Eva M., Carstensen, Helena, Hopster-Iversen, Charlotte, van Loon, Gunther, Decloedt, Annelies, van Steenkiste, Glenn, Marr, Celia M., Reef, Virginia B., Schwarzwald, Colin C., Mitchell, Katharyn J., Nostell, Katarina, Nogradi, Nora, Nielsen, Soren S., Carlson, Jonas, Platonov, Pyotr G., Buhl, Rikke, Hesselkilde, Eva M., Carstensen, Helena, Hopster-Iversen, Charlotte, van Loon, Gunther, Decloedt, Annelies, van Steenkiste, Glenn, Marr, Celia M., Reef, Virginia B., Schwarzwald, Colin C., Mitchell, Katharyn J., Nostell, Katarina, Nogradi, Nora, Nielsen, Soren S., Carlson, Jonas, and Platonov, Pyotr G.

Abstract

Background The recurrence rate of atrial fibrillation (AF) in horses after cardioversion to sinus rhythm (SR) is relatively high. Atrial fibrillatory rate (AFR) derived from surface ECG is considered a biomarker for electrical remodelling and could potentially be used for the prediction of successful AF cardioversion and AF recurrence. Objectives Evaluate if AFR was associated with successful treatment and could predict AF recurrence in horses. Study design Retrospective multicentre study. Methods Electrocardiograms (ECG) from horses with persistent AF admitted for cardioversion with either medical treatment (quinidine) or transvenous electrical cardioversion (TVEC) were included. Bipolar surface ECG recordings were analysed by spatiotemporal cancellation of QRST complexes and calculation of AFR from the remaining atrial signal. Kaplan-Meier survival curve and Cox regression analyses were performed to assess the relationship between AFR and the risk of AF recurrence. Results Of the 195 horses included, 74 received quinidine treatment and 121 were treated with TVEC. Ten horses did not cardiovert to SR after quinidine treatment and AFR was higher in these, compared with the horses that successfully cardioverted to SR (median [interquartile range]), (383 [367-422] vs 351 [332-389] fibrillations per minute (fpm), P < .01). Within the first 180 days following AF cardioversion, 12% of the quinidine and 34% of TVEC horses had AF recurrence. For the horses successfully cardioverted with TVEC, AFR above 380 fpm was significantly associated with AF recurrence (hazard ratio = 2.4, 95% confidence interval 1.2-4.8, P = .01). Main limitations The treatment groups were different and not randomly allocated, therefore the two treatments cannot be compared. Medical records and the follow-up strategy varied between the centres. Conclusions High AFR is associated with failure of quinidine cardioversion

Published
2022

13. Atrial fibrillatory rate as predictor of recurrence of atrial fibrillation in horses treated medically or with electrical cardioversion

Author

Buhl, Rikke; https://orcid.org/0000-0002-8201-0186, Hesselkilde, Eva M, Carstensen, Helena, Hopster‐Iversen, Charlotte, van Loon, Gunther; https://orcid.org/0000-0001-5191-5241, Decloedt, Annelies; https://orcid.org/0000-0001-8129-2006, Van Steenkiste, Glenn; https://orcid.org/0000-0002-0165-5215, Marr, Celia M; https://orcid.org/0000-0002-5093-5694, Reef, Virginia B; https://orcid.org/0000-0001-7332-7918, Schwarzwald, Colin C; https://orcid.org/0000-0002-6095-5402, Mitchell, Katharyn J; https://orcid.org/0000-0002-5545-5630, Nostell, Katarina; https://orcid.org/0000-0003-3306-8397, Nogradi, Nora, Nielsen, Søren S, Carlson, Jonas, Platonov, Pyotr G, Buhl, Rikke; https://orcid.org/0000-0002-8201-0186, Hesselkilde, Eva M, Carstensen, Helena, Hopster‐Iversen, Charlotte, van Loon, Gunther; https://orcid.org/0000-0001-5191-5241, Decloedt, Annelies; https://orcid.org/0000-0001-8129-2006, Van Steenkiste, Glenn; https://orcid.org/0000-0002-0165-5215, Marr, Celia M; https://orcid.org/0000-0002-5093-5694, Reef, Virginia B; https://orcid.org/0000-0001-7332-7918, Schwarzwald, Colin C; https://orcid.org/0000-0002-6095-5402, Mitchell, Katharyn J; https://orcid.org/0000-0002-5545-5630, Nostell, Katarina; https://orcid.org/0000-0003-3306-8397, Nogradi, Nora, Nielsen, Søren S, Carlson, Jonas, and Platonov, Pyotr G

Abstract

Background: The recurrence rate of atrial fibrillation (AF) in horses after cardioversion to sinus rhythm (SR) is relatively high. Atrial fibrillatory rate (AFR) derived from surface ECG is considered a biomarker for electrical remodelling and could potentially be used for the prediction of successful AF cardioversion and AF recurrence. Objectives: Evaluate if AFR was associated with successful treatment and could predict AF recurrence in horses. Study design: Retrospective multicentre study. Methods: Electrocardiograms (ECG) from horses with persistent AF admitted for cardioversion with either medical treatment (quinidine) or transvenous electrical cardioversion (TVEC) were included. Bipolar surface ECG recordings were analysed by spatiotemporal cancellation of QRST complexes and calculation of AFR from the remaining atrial signal. Kaplan-Meier survival curve and Cox regression analyses were performed to assess the relationship between AFR and the risk of AF recurrence. Results: Of the 195 horses included, 74 received quinidine treatment and 121 were treated with TVEC. Ten horses did not cardiovert to SR after quinidine treatment and AFR was higher in these, compared with the horses that successfully cardioverted to SR (median [interquartile range]), (383 [367-422] vs 351 [332-389] fibrillations per minute (fpm), P < .01). Within the first 180 days following AF cardioversion, 12% of the quinidine and 34% of TVEC horses had AF recurrence. For the horses successfully cardioverted with TVEC, AFR above 380 fpm was significantly associated with AF recurrence (hazard ratio = 2.4, 95% confidence interval 1.2-4.8, P = .01). Main limitations: The treatment groups were different and not randomly allocated, therefore the two treatments cannot be compared. Medical records and the follow-up strategy varied between the centres. Conclusions: High AFR is associated with failure of quinidine cardioversion and AF recurrence after successful TVEC. As a noninvasive marker that can be

Published
2022

16. Atrial fibrillatory rate as predictor of recurrence of atrial fibrillation in horses treated medically or with electrical cardioversion

Author

Buhl, Rikke, primary, Hesselkilde, Eva M., additional, Carstensen, Helena, additional, Hopster‐Iversen, Charlotte, additional, van Loon, Gunther, additional, Decloedt, Annelies, additional, Van Steenkiste, Glenn, additional, Marr, Celia M., additional, Reef, Virginia B., additional, Schwarzwald, Colin C., additional, Mitchell, Katharyn J., additional, Nostell, Katarina, additional, Nogradi, Nora, additional, Nielsen, Søren S., additional, Carlson, Jonas, additional, and Platonov, Pyotr G., additional

Published
2022
Full Text
View/download PDF

21. Nasal high flow oxygen therapy in hospitalised neonatal foals.

Author

Floyd, Emily, Danks, Sophie, Comyn, Imogen, Mackenzie, Catriona, and Marr, Celia M.

Abstract

Background: Respiratory disease is common in critically ill neonatal foals. Traditional oxygen therapy (TOT) with nasal insufflation of oxygen is often used to provide first‐line respiratory support. Mechanical ventilation is used in foals which require a greater level of support but requires specialist expertise and can be associated with significant complications. Non‐invasive ventilation (NIV) enables a greater level of respiratory support without the need for intubation. High flow oxygen therapy (HFOT) is a mode of NIV commonly used in human intensive care. Objectives: To describe the use of HFOT in hospitalised neonatal foals. Study design: Retrospective case series. Methods: Hospital records of neonatal foals admitted between 2018 and 2019 that received treatment with HFOT were reviewed. Clinical data and complications were recorded. Results: Fourteen foals were identified and the median duration of use was 43 hours (range 2‐93 hours) with a median flow rate of 0.7L/kg/min (range 0.42‐1.67). Ten foals survived to discharge. No significant complications associated with the technique were recorded. Main limitations: A small study population which was retrospectively reviewed. Conclusions: This study provides preliminary information about the clinical use of HFOT in neonatal foals. The technique was well tolerated and no significant adverse effects were noted. However, further study is required to evaluate efficacy. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

22. Contributors

Author

Balasuriya, Udeni B.R., primary, Barbet, Joy L., additional, Barnett, Susan E., additional, Bourgeois, Melissa Ann, additional, Burgess, Brandy A., additional, Byrne, Barbara A., additional, Conway, Julia A., additional, Davis, Elizabeth G., additional, Davis, Jennifer L., additional, Delcambre, Gretchen Henry, additional, Divers, Thomas J., additional, Duarte, Paulo C., additional, Bevilaqua Felippe, Maria Julia, additional, Freeman, David E., additional, Gebhart, Connie J., additional, Getman, Liberty M., additional, Ginn, Pamela E., additional, Greiner, Ellis C., additional, Grooters, Amy M., additional, Hernandez, Jorge A., additional, Hill, Ashley E., additional, Hinchcliff, Kenneth William, additional, Hines, Melissa T., additional, Kettle, Anthony N.B., additional, Knowles, Donald P., additional, Kristula, Michaela, additional, Landolt, Gabriele A., additional, Lohmann, Katharina L., additional, Long, Maureen T., additional, Lunn, D. Paul, additional, MacKay, Robert J., additional, Magdesian, K. Gary, additional, Mallicote, Martha, additional, Marr, Celia M., additional, Marsella, Rosanna, additional, McCluskey, Brian J., additional, Mealey, Robert H., additional, Middleton, Deborah, additional, Mittel, Linda D., additional, Morley, Paul S., additional, Ness, Sally Anne L., additional, Nielsen, Martin K., additional, Pearson, Lisa K., additional, Plummer, Caryn E., additional, Pusterla, Nicola, additional, Reinemeyer, Craig R., additional, Sanchez, Chris, additional, Savage, C.J. (Kate), additional, Sears, Kelly P., additional, Seino, Kathy K., additional, Sellon, Debra C., additional, Slater, Josh, additional, Spier, Sharon J., additional, Tibary, Ahmed, additional, Timoney, Peter J., additional, Townsend, Hugh G.G., additional, Traub-Dargatz, Josie L., additional, van Laaren, Karl, additional, Walden, Heather Stockdale, additional, Waller, Andrew Stephen, additional, Weese, J. Scott, additional, Whitcomb, Mary Beth, additional, Wilkins, Pamela A., additional, Wilson, W. David, additional, Wise, L. Nicki, additional, Witonsky, Sharon, additional, and Zimmel, Dana N., additional

Published
2014
Full Text
View/download PDF

26. Contributors

Author

Bain, Fairfield T., primary, Blissitt, Karen, additional, Bowen, Mark, additional, McIntosh Bright, Janice, additional, Cox, Alistair, additional, Durando, Mary, additional, Elliott, Jonathan, additional, Evans, David, additional, Fogerty, Ursula, additional, Foote, Alastair, additional, van Loon, Gunther, additional, Hallowell, Gayle, additional, Keen, John, additional, Marr, Celia M., additional, Milne, Elspeth, additional, Mogg, Tony D., additional, de Solis, Cristobal Navas, additional, Patteson, Mark, additional, Piercy, Richard, additional, Reef, Virginia, additional, Reimer, Johanna, additional, Robertson, Sheilah, additional, Sage, Abby, additional, Seco, Olga, additional, Thomas, William, additional, Underwood, Claire, additional, and Young, Lesley, additional

Published
2010
Full Text
View/download PDF

39. Contributors

Author

Arguedas, Marta Gonzalez, primary, Balasuriya, Udeni B.R., additional, Barbet, Joy L., additional, Barton, Michelle Henry, additional, Bertone, Alicia L., additional, Besser, Thomas E., additional, Brown, Corrie C., additional, Byrne, Barbara A., additional, Carrillo, Natalie Ann, additional, Cary, Julie A., additional, Colitz, Carmen M.H., additional, Davis, Elizabeth G., additional, Davis, Jennifer L., additional, Piero, Fabio Del, additional, DiPietro, Joseph A., additional, Divers, Thomas J., additional, Drolet, Richard, additional, Duarte, Paulo C., additional, Dubey, J.P., additional, Dunowska, Magdalena, additional, Dwyer, Roberta M., additional, Fite, Cheryl L., additional, Felippe Flaminio, Maria Julia Bevilaqua, additional, Freeman, David E., additional, Garten, Wolfgang, additional, Gibbs, E. Paul J., additional, Ginn, Pamela E., additional, Grabner, Arthur, additional, Greiner, Ellis C., additional, Grooters, Amy M., additional, Guthrie, Alan J., additional, Hardy, Joanne, additional, Herden, Christiane, additional, Herzog, Sibylle, additional, Higgins, Jill, additional, Hill, Ashley E., additional, Hinchcliff, Kenneth W., additional, Hines, Melissa T., additional, Jordan, Merijo Eileen, additional, Knowles, Donald P., additional, Kohn, Catherine, additional, Kristula, Michaela, additional, Kuonen, Vanessa, additional, Landolt, Gabriele A., additional, Lavoie, Jean-Pierre, additional, Logas, Dawn, additional, Lohmann, Katharina L., additional, Lunn, D. Paul, additional, MacKay, Robert J., additional, MacLachlan, N. James, additional, Madigan, John E., additional, Marr, Celia M., additional, Marsella, Rosanna, additional, McCluskey, Brian J., additional, Mealey, Robert H., additional, Morley, Paul S., additional, Newton, J. Richard, additional, Nicoletti, Paul L., additional, Nielsen, Martin Krarup, additional, Oaks, J. Lindsay, additional, Pappagianis, Demosthenes, additional, Papich, Mark G., additional, Peek, Simon F., additional, Pusterla, Nicola, additional, Reinemeyer, Craig R., additional, Richt, Juergen A., additional, Rothschild, Chantal M., additional, Sanchez, L. Chris, additional, Seino, Kathy K., additional, Slater, Josh, additional, Spier, Sharon J., additional, Studdert, Michael J., additional, Sutter, W. Wesley, additional, Sweeney, Corinne R., additional, Tibary, Ahmed, additional, Timoney, Peter J., additional, Townsend, Hugh G.G., additional, Traub-Dargatz, Josie L., additional, VanMetre, David C., additional, Weese, J. Scott, additional, Beth Whitcomb, Mary, additional, Wilkins, Pamela A., additional, Wilson, W. David, additional, and Zimmel, Dana N., additional

Published
2007
Full Text
View/download PDF

41. Contributors

Author

Baker, Gordon J., primary, Bertone, Joseph J., additional, Bowen, Mark, additional, Butler, Carolyn L., additional, Carnevale, Elaine M., additional, Cary, Julie A., additional, Chandler, Keith J., additional, Cohen, Noah D., additional, Davis, Elizabeth G., additional, Divers, Thomas J., additional, Donaldson, Lydia L., additional, Estep, Daniel Q., additional, Fischer, A.T., additional, Holland, Robert E., additional, Kenney, James D., additional, Lagoni, Laurel, additional, Lohmann, Katharina L., additional, Long, Maureen T., additional, Long, Rachel E., additional, Loving, Nancy S., additional, Marr, Celia M., additional, Matthews, Andrew G., additional, McCormick, William H., additional, McKeever, Kenneth Harrington, additional, Menzies-Gow, Nicola J., additional, Messer, Nat T., additional, Perkins, Gillian A., additional, Ralston, Sarah L., additional, Rush, Bonnie R., additional, Shettko, Donna L., additional, Traub-Dargatz, Josie L., additional, Turner, Tracy A., additional, and Valentine, Beth A., additional

Published
2006
Full Text
View/download PDF

43. Fundamentals of arrhythmogenic mechanisms and treatment strategies for equine atrial fibrillation.

Author

Premont, Antoine, Balthes, Samantha, Marr, Celia M., and Jeevaratnam, Kamalan

Abstract

Atrial fibrillation (AF) is the most common pathological arrhythmia in horses. Although it is not usually a life‐threatening condition on its own, it can cause poor performance and make the horse unsafe to ride. It is a complex multifactorial disease influenced by both genetic and environmental factors including exercise training, comorbidities or ageing. The interactions between all these factors in horses are still not completely understood and the pathophysiology of AF remains poorly defined. Exciting progress has been recently made in equine cardiac electrophysiology in terms of diagnosis and documentation methods such as cardiac mapping, implantable electrocardiogram (ECG) recording devices or computer‐based ECG analysis that will hopefully improve our understanding of this disease. The available pharmaceutical and electrophysiological treatments have good efficacy and lead to a good prognosis for AF, but recurrence is a frequent issue that veterinarians have to face. This review aims to summarise our current understanding of equine cardiac electrophysiology and pathophysiology of equine AF while providing an overview of the mechanism of action for currently available treatments for equine AF. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

47. Letters to the Editor

Author

Bowen, Mark, primary, Ivens, Philip, additional, Lawrence, Hattie, additional, Marr, Celia, additional, Newton, Richard, additional, Paillot, Romain, additional, Rash, Adam, additional, and Rendle, David, additional

Published
2020
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results